Orientador(es)
Resumo(s)
Ethambutol (EMB) is a first-line antitubercular drug that inhibits arabinogalactan and lipoarabinomannan biosynthesis. Resistance to EMB has traditionally been associated with embB mutations, especially in the Met306 codon. In this study, the region encom. - Fundacao Calouste Gulbenkian, Lisbon, Portugal [FCG 001013]. - Funding: This work was supported by Fundacao Calouste Gulbenkian, Lisbon, Portugal (grant FCG 001013).
Descrição
Palavras-chave
Infectious Diseases Microbiology Pharmacology & Pharmacy
Contexto Educativo
Citação
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. - Vol. 33, n. 4 (APR 2009), p. 334-338
Editora
ELSEVIER SCIENCE BV